PF-06730110

N/A

Report date: 2025/11/20 17:57:01

NME

Base Information

Drug NamePF-06730110

Drug Alias NamePF-06730110[18F]MNI-968

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5]

Mechanisms of ActionDopamine D1 receptor modulators

TargetsDopamine D1 receptor

Therapy Area/IndicationsNerve Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesInvicro Llc

China Registration ClassN/A

Develop Information

Active CompaniesInvicro Llc

Inactive CompaniesMolecular Neuroimaging Llc

Active IndicationsNerve Degeneration

Inactive IndicationsN/A

Other Information

ATC CodeN/A